Published in:
01-06-2012 | Clinical Investigation
Uterine Artery Embolization versus Myomectomy: Impact on Quality of Life—Results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial
Authors:
Isaac T. Manyonda, Mark Bratby, Jessica S. Horst, Nassera Banu, Maha Gorti, Anna-Maria Belli
Published in:
CardioVascular and Interventional Radiology
|
Issue 3/2012
Login to get access
Abstract
Purpose
This study was designed to compare quality of life (QoL) outcomes after uterine artery embolization (UAE) or myomectomy.
Methods
Women with symptomatic fibroids diagnosed by ultrasound who wished to preserve their uterus were randomized to myomectomy (n = 81) or UAE (n = 82). Endpoints at 1 year were QoL measured by a validated questionnaire, hospital stay, rates of complications, and need for reintervention.
Results
UAE patients had shorter hospitalization (2 vs. 6 days, p < 0.001). By 1 year postintervention, significant and equal improvements in QoL scores had occurred in both groups (myomectomy n = 59; UAE n = 61). There had been two (2.9%) major complications among UAE versus 6 (8%) among myomectomy patients (not significant). By 2 years, among UAE patients (n = 57) there were eight (14.0%) reinterventions for inadequate symptom control compared with one (2.7%) among myomectomy patients (n = 37). Half of the women who required hysterectomy had concomitant adenomyosis missed by US.
Conclusions
UAE and myomectomy both result in significant and equal improvements in QoL. UAE allows a shorter hospital stay and fewer major complications but with a higher rate of reintervention.